carcinoma
Let an agent give general, non-diagnostic information about carcinoma, route people to cancer services and support, and avoid prognosis for individuals.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify
Researched by: Claude
Purpose and description
Let an agent give general, non-diagnostic information about carcinoma, route people to cancer services and support, and avoid prognosis for individuals.
A cancer that arises from epithelial cells, which line the surfaces and cavities of the body; the most common type of cancer, including many cancers of the skin, breast, lung, colon and prostate.
What it is for: A category of cancer diagnosed and treated by oncology teams.
It can be seek assessment for warning signs; join cancer screening programmes; find reputable cancer information and support; discuss treatment options with the care team.
Distinguishing features
Cancer of epithelial origin
Most common cancer type
Many subtypes by cell and organ
Treatment depends on type and stage
What it looks like
Not described; diagnosis is by clinical examination, imaging and pathology.
How it is recognised
Types such as squamous cell carcinoma or adenocarcinoma
Diagnosed by pathology
Carcinoma of unknown primary is a specific situation
Related models
is a kind of - category
arises from - tissue
is treated by - professionals
is detected by - methods
In practice
Families and kinds
squamous cell carcinoma
adenocarcinoma
basal cell carcinoma
transitional cell carcinoma
neuroendocrine carcinoma
Identifiers
ICD-O-3 morphology 8010/3 and related codes carcinoma codes
Standards and regulation
TNM staging (UICC/AJCC)
National cancer screening programmes
Clinical guidelines such as NCCN and ESMO
Failure modes and hazards
Giving individual prognosis
Diagnosis by an agent
Promoting unproven treatments
Also called
+390
Where this came from
wikidata · CC0 1.0
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.
Concern Getting checked.
Assessment comes first.
Warning signs
See a doctor.
Warning
Warning signs.
- Should this symptom be checked by a doctor promptly? boundary
- Is there an urgent referral route? action
Screening
Programmes.
Screening
Screening.
- Which screening programmes are available to this person? provenance
- How are they accessed? action
Understanding Types and staging.
Information must be general.
Type
Subtype.
Type
Subtype.
- Which carcinoma subtype is meant? definition
- Which organ is involved? definition
Staging
TNM.
Staging
Staging.
- What does staging mean in general terms? definition
- Who can explain an individual stage? boundary
Care Treatment.
The care team decides.
Options
Treatment types.
Options
Treatment options.
- Which treatment types do guidelines describe for this type? provenance
- Who decides with the patient? boundary
Trials
Clinical trials.
Trials
Clinical trials.
- How can someone find registered clinical trials? action
- Should they ask their team? action
Support People affected.
Support matters.
Services
Support organisations.
Services
Support services.
- Which cancer support services and helplines are available? action
- Is emotional support available for families? action
Claims
Unproven treatments.
Claims
Unproven claims.
- Is a claimed cure supported by evidence? provenance
- Who can advise? action
What the second pass must settle
- Should carcinoma subtypes be separate entries?
- How should support services be localised?
- How should staging be explained without prognosis?